SCHEMBL17523299

SCHEMBL17523299

C[C@]1(c2ccccc2)OC(=O)C[C@H]1c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.46
RCOR1 Q9UKL0 4/20 0.46
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 1/20 0.44
RORC P51449 2/20 0.43
LIG1 P18858 1/20 0.40
HSD11B1 P28845 1/20 0.39
MDM2 Q00987 1/20 0.37
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523301 1.00 KDM1A (0.46) KDM1ARCOR1CYP2C9CYP2C19RORC
SCHEMBL17523295 0.94 CYP2C9 (0.44) KDM1ARCOR1CYP2C9CYP2C19RORC
SCHEMBL17523304 0.94 CYP2C9 (0.44) KDM1ARCOR1CYP2C9CYP2C19RORC
SCHEMBL17523290 0.90 KDM1A (0.42) KDM1ACYP2C19HSD11B1CYP3A4CYP2D6
SCHEMBL17523288 0.90 KDM1A (0.42) KDM1ACYP2C19HSD11B1CYP3A4CYP2D6
SCHEMBL17523298 0.87 SLC6A9 (0.40) KDM1ACYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL17523297 0.87 SLC6A9 (0.40) KDM1ACYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL17523300 0.86 LIG1 (0.40) KDM1ARCOR1CYP2C19RORCLIG1
SCHEMBL17523305 0.86 LIG1 (0.40) KDM1ARCOR1CYP2C19RORCLIG1
SCHEMBL17523291 0.81 SLC6A9 (0.40) KDM1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039827-A1 ACTIVATION OF CARBONYL BETA-CARBONS FOR CHEMICAL TRANSFORMATIONS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039827-A1 ACTIVATION OF CARBONYL BETA-CARBONS FOR CHEMICAL TRANSFORMATIONS CBR1, CBR3, CAT KDM1A 3183/4885RCOR1 2801/4885CYP2C9 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.